Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2024-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$215.8m reported value +45.4% vs Q2 2024
36positions
76.0%in top 10
2 new 4 added 6 reduced 1 sold out vs Q2 2024

Holdings, Q3 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APPLIED THERAPEUTICS INC COM APLT APLT 5,574,687 $47.4m21.96% 21.96% UnchangedShares held: Q4 2023 5.5m, Q1 2024 5.6m, Q2 2024 5.6m, Q3 2024 5.6m
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 710,422 $35.5m16.45% 16.45% UnchangedShares held: Q4 2023 490.4k, Q1 2024 490.4k, Q2 2024 710.4k, Q3 2024 710.4k
3 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $29.5m13.68% 13.68% UnchangedShares held: Q4 2023 5.5m, Q1 2024 5.5m, Q2 2024 5.5m, Q3 2024 5.5m
4 ALAMOS GOLD INC NEW COM CL A AGI AGI 41,000 $8.8m4.09% 4.09% ReducedShares held: Q4 2023 80.0k, Q1 2024 80.0k, Q2 2024 80.0k, Q3 2024 41.0k -39.0k -39,000 -48.8%
5 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $7.9m3.65% 3.65% UnchangedShares held: Q4 2023 600.0k, Q1 2024 600.0k, Q2 2024 600.0k, Q3 2024 600.0k
6 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $7.8m3.60% 3.60% UnchangedShares held: Q4 2023 0, Q1 2024 32.0k, Q2 2024 32.0k, Q3 2024 32.0k
7 ENTERA BIO LTD SHS ENTX ENTX 3,881,879 $7.4m3.42% 3.42% UnchangedShares held: Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 3.9m, Q3 2024 3.9m
8 HOOKIPA PHARMA INC COM COM 551,738 $7.2m3.33% 3.33% ReducedShares held: Q4 2023 5.5m, Q1 2024 5.5m, Q2 2024 5.5m, Q3 2024 551.7k -5.0m -4,965,647 -90.0%
9 ALTIMMUNE INC COM NEW ALT ALT 1,121,524 $6.9m3.19% 3.19% UnchangedShares held: Q4 2023 200.0k, Q1 2024 567.2k, Q2 2024 1.1m, Q3 2024 1.1m
10 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $5.8m2.67% 2.67% UnchangedShares held: Q4 2023 200.0k, Q1 2024 200.0k, Q2 2024 200.0k, Q3 2024 200.0k
11 SEABRIDGE GOLD INC COM COM 317,003 $5.3m2.47% 2.47% AddedShares held: Q4 2023 246.6k, Q1 2024 246.6k, Q2 2024 246.6k, Q3 2024 317.0k +70.4k +70,406 28.6%
12 OCULAR THERAPEUTIX INC COM OCUL OCUL 600,400 $5.2m2.42% 2.42% AddedShares held: Q4 2023 200.4k, Q1 2024 200.4k, Q2 2024 200.4k, Q3 2024 600.4k +400.0k +400,000 199.6%
13 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $5.2m2.42% 2.42% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 1.2m
14 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $4.5m2.07% 2.07% UnchangedShares held: Q4 2023 55.5k, Q1 2024 55.5k, Q2 2024 55.5k, Q3 2024 55.5k
15 KINROSS GOLD CORP COM KGC KGC 440,000 $4.1m1.91% 1.91% UnchangedShares held: Q4 2023 440.0k, Q1 2024 440.0k, Q2 2024 440.0k, Q3 2024 440.0k
16 EQUINOX GOLD CORP COM EQX EQX 550,811 $3.4m1.55% 1.55% UnchangedShares held: Q4 2023 420.9k, Q1 2024 550.8k, Q2 2024 550.8k, Q3 2024 550.8k
17 FRANCO NEV CORP COM FNV FNV 25,000 $3.1m1.44% 1.44% UnchangedShares held: Q4 2023 0, Q1 2024 25.0k, Q2 2024 25.0k, Q3 2024 25.0k
18 SKEENA RES LTD NEW COM SKE SKE 315,400 $2.7m1.24% 1.24% AddedShares held: Q4 2023 0, Q1 2024 38.8k, Q2 2024 38.8k, Q3 2024 315.4k +276.6k +276,614 713.2%
19 MAG SILVER CORP COM MAG MAG 170,000 $2.4m1.11% 1.11% ReducedShares held: Q4 2023 105.0k, Q1 2024 275.0k, Q2 2024 275.0k, Q3 2024 170.0k -105.0k -105,000 -38.2%
20 ISHARES SILVER TR ISHARES SLV SLV 80,000 $2.3m1.05% 1.05% AddedShares held: Q4 2023 0, Q1 2024 48.5k, Q2 2024 48.5k, Q3 2024 80.0k +31.5k +31,500 65.0%
21 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $2.1m0.98% 0.98% UnchangedShares held: Q4 2023 13.0k, Q1 2024 13.0k, Q2 2024 13.0k, Q3 2024 13.0k
22 VISA INC COM CL A V V 4,850 $1.3m0.62% 0.62% UnchangedShares held: Q4 2023 4.8k, Q1 2024 4.8k, Q2 2024 4.8k, Q3 2024 4.8k
23 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.2m0.56% 0.56% UnchangedShares held: Q4 2023 10.0k, Q1 2024 10.0k, Q2 2024 10.0k, Q3 2024 10.0k
24 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.1m0.53% 0.53% UnchangedShares held: Q4 2023 7.7k, Q1 2024 7.7k, Q2 2024 7.7k, Q3 2024 7.7k
25 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.1m0.53% 0.53% UnchangedShares held: Q4 2023 2.2k, Q1 2024 2.2k, Q2 2024 2.2k, Q3 2024 2.2k
26 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $1.1m0.50% 0.50% UnchangedShares held: Q4 2023 160.5k, Q1 2024 260.5k, Q2 2024 260.5k, Q3 2024 260.5k
27 ROYAL GOLD INC COM RGLD RGLD 7,550 $1.1m0.49% 0.49% UnchangedShares held: Q4 2023 7.5k, Q1 2024 7.5k, Q2 2024 7.5k, Q3 2024 7.5k
28 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $947.3k0.44% 0.44% UnchangedShares held: Q4 2023 0, Q1 2024 6.8k, Q2 2024 6.8k, Q3 2024 6.8k
29 CVS HEALTH CORP COM CVS CVS 14,500 $911.8k0.42% 0.42% UnchangedShares held: Q4 2023 14.5k, Q1 2024 14.5k, Q2 2024 14.5k, Q3 2024 14.5k
30 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $763.5k0.35% 0.35% ReducedShares held: Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k, Q3 2024 12.5k -47.5k -47,500 -79.2%
31 NEW PAC METALS CORP COM NEWP NEWP 485,000 $722.6k0.33% 0.33% UnchangedShares held: Q4 2023 485.0k, Q1 2024 485.0k, Q2 2024 485.0k, Q3 2024 485.0k
32 SILVERCREST METALS INC COM SIL SIL 60,000 $555.0k0.26% 0.26% ReducedShares held: Q4 2023 470.0k, Q1 2024 470.0k, Q2 2024 470.0k, Q3 2024 60.0k -410.0k -410,000 -87.2%
33 Orgenesis, Inc. COM COM 63,473 $283.1k0.13% 0.13% ReducedShares held: Q4 2023 634.7k, Q1 2024 634.7k, Q2 2024 634.7k, Q3 2024 63.5k -571.3k -571,265 -90.0%
34 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $198.0k0.09% 0.09% UnchangedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 100.0k, Q3 2024 100.0k
35 OPUS GENETICS INC COM IRD IRD 100,000 $131.0k0.06% 0.06% UnchangedShares held: Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k, Q3 2024 100.0k
36 GRAIL INC COM GRAL GRAL 100 $1.4k0.00% 0.00% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 100

Sold out since Q2 2024

SecurityTickerShares held beforeValue then
GLOBAL X FDS SIL SIL 45,175 $1.4m45.2k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08